Form 4: Esperion Therapeutics General Counsel Sells Shares to Cover Tax Obligations
Insider Transaction Report
Esperion Therapeutics' General Counsel, Benjamin Looker, sold 6,422 shares of common stock on June 17, 2025, at $1.152 per share to satisfy tax obligations on vested restricted stock units.
Summary
- Benjamin Looker, the General Counsel of Esperion Therapeutics, Inc. (ESPR), reported the sale of 6,422 shares of the company's common stock.
- The transaction took place on June 17, 2025, with shares sold at a price of $1.152 per share.
- The purpose of the sale was explicitly stated as satisfying tax obligations associated with vested restricted stock units.
- Following this transaction, Mr. Looker's beneficial ownership of Esperion Therapeutics common stock stands at 401,241 shares.
Sentiment
Score: 5
Explanation: The transaction is a routine sale to cover tax obligations on vested equity, which is a neutral event and does not indicate a change in sentiment towards the company's prospects.
Future Outlook
NA
Industry Context
This Form 4 filing is a routine disclosure of an insider stock transaction, specifically a sale by the General Counsel to cover tax obligations. It does not provide broader insights into industry trends or competitive landscape, as it pertains to an individual's compensation-related stock activity.
Related Party Transactions
- The transaction involves an officer of Esperion Therapeutics, Benjamin Looker, selling company stock, which is by definition a related party transaction under SEC rules for insider reporting.
Stakeholder Impact
- Shareholders: The sale of 6,422 shares by an insider is a minor dilution relative to the total shares outstanding and is a routine event for tax purposes, unlikely to have a significant direct impact on shareholder value.
- Employees: No direct impact on employees is indicated.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.
Key Dates
| Date | Description |
|---|---|
| 2021-12-13 | Date Benjamin Looker granted Limited Power of Attorney to Sheldon Koenig and Richard Bartram for SEC filings. |
| 2025-06-17 | Date of common stock transaction by Benjamin Looker. |
| 2025-06-18 | Date the Form 4 was signed by Sheldon L. Koenig, by power of attorney. |
Keywords
Esperion Therapeutics, ESPR, Form 4, Insider Trading, Stock Sale, Benjamin Looker, General Counsel, Tax Obligation, Restricted Stock Units, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.